Department of Physical Therapy, 16751University of Murcia, Murcia, Spain.
Research Group Fisioterapia y Discapacidad, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain.
Chron Respir Dis. 2022 Jan-Dec;19:14799731221119810. doi: 10.1177/14799731221119810.
To determine if pre-frail Chronic obstructive pulmonary disease (COPD) patients with poor and non-poor performance in the five-repetition sit-to-stand test (5-STS) had a worse prognosis for hospitalization and mortality at 2 years and for mortality at 5 years than non-frail patients.
We prospectively included patients with stable COPD, between 40 and 80 years, from a hospital in Spain. Patients were classified according their performance on the 5-STS test and level of frailty. Timing, number of hospitalizations, length of stay, and timing and rate of mortality were outcome measures. Patients were followed for 2 years for exacerbations and for 5 years for mortality. Kaplan-Meier curves and univariate and multivariate Cox proportional-hazard analyses, ANOVA tests and univariate and multivariate linear and logistic regression models were used.
Of the 125 patients included, 25.6% were pre-frail with poor performance, 57% pre-frail with non-poor performance, and 17.4% non-frail with non-poor performance. Pre-frail patients with poor performance had a higher number of hospitalizations (adjusted beta: 0.49; 95% CI: 0.01-0.96), mortality rates (odds ratio: 11.33; 95% CI: 1.15-110.81), and risk at 5 years (adjusted hazard ratio: 8.77; 95% CI: 1.02-75.51) than non-frail patients. Pre-frail patients with poor performance also had worse prognoses than non-frail patients with respect to length of hospital stays (increased by 4.16 days) and timing to first hospitalization (HR: 6.01) in unadjusted models, but not when adjusted.
The COPD prognosis of pre-frail patients with respect to the number of exacerbations with hospitalization and the timing and rate of mortality is dependent of functional performance.
确定在五次重复坐立试验(5-STS)中表现差和非差的衰弱前期慢性阻塞性肺疾病(COPD)患者与非衰弱患者相比,2 年时住院和死亡率以及 5 年时死亡率的预后是否更差。
我们前瞻性纳入了来自西班牙一家医院的 40 至 80 岁稳定期 COPD 患者。根据 5-STS 测试和虚弱程度对患者进行分类。观察终点为住院时间、住院次数、住院时间、死亡时间和死亡率。患者随访 2 年以观察加重情况,随访 5 年以观察死亡情况。采用 Kaplan-Meier 曲线和单因素及多因素 Cox 比例风险分析、方差分析和单因素及多因素线性和逻辑回归模型。
在纳入的 125 名患者中,25.6%为衰弱前期且表现差,57%为衰弱前期且表现非差,17.4%为非衰弱且表现非差。表现差的衰弱前期患者住院次数更多(调整后β:0.49;95%CI:0.01-0.96)、死亡率更高(优势比:11.33;95%CI:1.15-110.81)、5 年风险更高(调整后危险比:8.77;95%CI:1.02-75.51),而非衰弱前期患者。在未调整模型中,与非衰弱前期患者相比,表现差的衰弱前期患者的住院时间(增加 4.16 天)和首次住院时间(HR:6.01)也较差,但在调整后模型中则不然。
衰弱前期 COPD 患者的住院和死亡率随时间变化的预后取决于功能表现。